| Neda Dragisic, | |
|
970 W El Camino Real Ste 1, Sunnyvale, CA 94087-1180 | |
| (650) 282-5555 | |
| Not Available |
| Full Name | Neda Dragisic |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 970 W El Camino Real Ste 1, Sunnyvale, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720795818 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 108203 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Neda Dragisic, 2000 Crystal Springs Rd Apt 1840, San Bruno, CA 94066-4647 Ph: (310) 721-7500 | Neda Dragisic, 970 W El Camino Real Ste 1, Sunnyvale, CA 94087-1180 Ph: (650) 282-5555 |
News Archive
Building on their earlier work, Johns Hopkins researchers have discovered that an apparently nontoxic cellular "energy blocker" can eradicate large liver tumors grown in rats. Six months to more than a year after treatment was stopped, the rats are still cancer free.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
Prescription opioid abuse has reached epidemic levels in the past 15 years. Scientists investigating why people favor one drug over another have found that oxycodone and hydrocodone are the drugs of choice for 75% of opioid-dependent individuals.
A University of Houston researcher is an author on a landmark multi-institutional genetic study of the most aggressive and common form of ovarian cancer that is published in the current issue of the scientific journal Nature.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 9 days ago
Dr. Sheetal S Gokhale, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 697 E Remington Dr Ste B, Sunnyvale, CA 94087 Phone: 408-245-0600 Fax: 408-245-0047 | |
Dr. Wade W Lee, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 685 E Remington Dr Ste B, Sunnyvale, CA 94087 Phone: 408-737-9633 | |
Grace Hsiao-fei Chyuwei, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1210 E Arques Ave, Suite 212, Sunnyvale, CA 94085 Phone: 408-749-9018 Fax: 408-749-9048 | |
Dr. Tetyana Iosifovna Varnava, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 660 S Bernardo Ave Ste 3, Sunnyvale, CA 94087 Phone: 408-523-1400 Fax: 408-523-1444 | |
Dr. Rob M Cisneros, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 990 W Fremont Ave Ste A, Sunnyvale, CA 94087 Phone: 408-738-0656 | |
Dr. Varsha Y Patel, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 990 W Fremont Ave, Suite C, Sunnyvale, CA 94087 Phone: 408-720-8555 | |
Dr. Kalaivani K Kulandaivelu, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 990 W Fremont Ave, Suite Y, Sunnyvale, CA 94087 Phone: 408-735-7161 Fax: 408-735-7173 |